The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Influenza B breakthrough: promising targets for vaccine development

10 May 2024

Influenza B breakthrough: promising targets for vaccine development

Influenza B viruses are often overlooked but can cause significant illness and mortality, especially in children. Little is known about how the immune system interacts with these viruses, however a recent breakthrough by researchers at the Doherty Institute may revolutionise how we are protected against influenza B and for longer periods.

Tejas Menon, co-author of the recent discovery and PhD Candidate at the Doherty Institute, explains how the immune system consistently recognises fragments of influenza B viruses, which opens up potential new targets for vaccine development.

Show notes:

News story: New frontiers in influenza B research: Breakthrough unveils promising targets for vaccine development

Peer review: Menon T, Illing P, Chaurasia P, et al. CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age. Nature Communications (2024). DOI: https://doi.org/10.1038/s41467-024-47576-y  

Get in touch

Have a question or topic you'd like us to explore in a future episode? Contact us via email doherty-media@unimelb.edu.au

Podcast Archive